June 29th 2021 The news agencies are all abuzz with the recent medical breakthrough of a dissolvable pacemaker (e.g. here, here, and here). We have yet another medical breakthrough thanks to #AnimalResearch, but as can be seen from those reports, news agencies persist in deemphasizing the vital role that research with animals played. We therefore … Continue reading #MPAR Dissolvable pacemaker developed #InAnimals
June 22nd, 2021 While much has been written about the various COVID-19 vaccines (prevention), including here are Speaking of Research, less emphasis has been placed on the treatment of COVID-19 patients—both earlier on in the pandemic and even at present. Part of this relates to some inherent skepticism of the value of using existing treatments … Continue reading Safety of COVID-19 antibody treatment tested #InMice #InMonkeys
June 21st 2021 Public misinformation and disinformation can only benefit from poor descriptions and inaccurate labeling. As we have pointed out over and over again, there is a desperate need, now more than ever, to provide accurate information to stakeholders concerning how, whether and why animals are needed for and used in research. It is … Continue reading Call for transparent labeling of news and journal articles #InMice
June 16, 2021 This guest post was written by Matthew R. Bailey, president; Eva Maciejewski, director of communications; and Leah Jessen, digital communication manager, Foundation for Biomedical Research The research community has a prime opportunity to educate the so-called moveable middle with facts about why animal research is necessary for medical advancements, polling data show. … Continue reading Unveiled: The Moveable Middle on Animal Research Is Larger Than We Thought
June 4th 2021 June is Pride Month! 🏳️🌈 And this year, Pride Month follows a particularly tumultuous legislative period in the U.S with respect to LGBTQIA health. Recently, news about states introducing or passing legislation to restrict or ban the use of medical treatments aimed at treating transgender youth has been fast and furious. Lawmakers … Continue reading Puberty blockers are all over the news (and laws). How did they come about?
June 3rd 2021 Recently, the FDA approved an Amgen drug, sotorasib, for non-small cell lung cancer (NSCLS) with a specific mutation in a gene known as Kirsten rat sarcoma viral oncogene homolog (KRAS) in patients whose disease has worsened after treatment with chemotherapy or other medicines. This mutation accounts for 13% of NSCLS—the most common … Continue reading FDA approves lung cancer drug #MPAR